Skip to content
10-Q

Quarterly Report

RAPT Therapeutics, Inc.

0001193125-25-268141

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 3, 2025 27.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.96M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.95M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 4.86M sh
Shares Diluted restated Q3 2025 · Sep 30, 2024 4.85M sh
Capex Q3 2025 · Sep 30, 2025 $83K
Capex Q3 2025 · Sep 30, 2024 $121K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$76.14M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$72.86M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $37.93M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $169.74M
Stockholders Equity Q3 2025 · Sep 30, 2025 $151.98M
Stockholders Equity Q3 2025 · Jun 30, 2025 $164.41M
Stockholders Equity Q3 2025 · Mar 31, 2025 $177.37M
Stockholders Equity Q3 2025 · Dec 31, 2024 $189.9M
Stockholders Equity Q3 2025 · Sep 30, 2024 $95.51M
Stockholders Equity Q3 2025 · Jun 30, 2024 $109.22M
Stockholders Equity Q3 2025 · Mar 31, 2024 $130.84M
Stockholders Equity Q3 2025 · Dec 31, 2023 $147.04M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.38M
Current Liabilities Q3 2025 · Dec 31, 2024 $48.35M
Total Liabilities Q3 2025 · Sep 30, 2025 $13.76M
Total Liabilities Q3 2025 · Dec 31, 2024 $50.42M
Current Assets Q3 2025 · Sep 30, 2025 $161.05M
Current Assets Q3 2025 · Dec 31, 2024 $235.24M
Total Assets Q3 2025 · Sep 30, 2025 $165.74M
Total Assets Q3 2025 · Dec 31, 2024 $240.33M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.65
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.94
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$3.79
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$15.80
Eps Basic Q3 2025 · Sep 30, 2025 −$0.65
Eps Basic Q3 2025 · Sep 30, 2025 −$1.94
Eps Basic restated Q3 2025 · Sep 30, 2024 −$3.79
Eps Basic restated Q3 2025 · Sep 30, 2024 −$15.80
Sga Expense Q3 2025 · Sep 30, 2025 $7.34M
Sga Expense Q3 2025 · Sep 30, 2025 $21.76M
Sga Expense Q3 2025 · Sep 30, 2024 $6.45M
Sga Expense Q3 2025 · Sep 30, 2024 $20.88M
Rd Expense Q3 2025 · Sep 30, 2025 $12.03M
Rd Expense Q3 2025 · Sep 30, 2025 $36.42M
Rd Expense Q3 2025 · Sep 30, 2024 $13.34M
Rd Expense Q3 2025 · Sep 30, 2024 $60.76M
Net Income Q3 2025 · Sep 30, 2025 −$17.58M
Net Income Q3 2025 · Sep 30, 2025 −$52.39M
Net Income Q3 2025 · Jun 30, 2025 −$17.64M
Net Income Q3 2025 · Mar 31, 2025 −$17.17M
Net Income Q3 2025 · Sep 30, 2024 −$18.43M
Net Income Q3 2025 · Sep 30, 2024 −$76.62M
Net Income Q3 2025 · Jun 30, 2024 −$27.66M
Net Income Q3 2025 · Mar 31, 2024 −$30.52M
Operating Income Q3 2025 · Sep 30, 2025 −$19.37M
Operating Income Q3 2025 · Sep 30, 2025 −$58.17M
Operating Income Q3 2025 · Sep 30, 2024 −$19.79M
Operating Income Q3 2025 · Sep 30, 2024 −$81.64M